Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C45H48ClN7O8S |
| Molecular Weight | 882.423 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[O-][N+](=O)C1=CC(=CC=C1NC[C@H]2COCCO2)S(=O)(=O)NC(=O)C3=CC=C(C=C3OC4=CN=C5NC=CC5=C4)N6CCN(CC7=C(CC8(CCC8)CC7)C9=CC=C(Cl)C=C9)CC6
InChI
InChIKey=FNBXDBIYRAPDPI-BHVANESWSA-N
InChI=1S/C45H48ClN7O8S/c46-33-4-2-30(3-5-33)39-25-45(12-1-13-45)14-10-32(39)28-51-16-18-52(19-17-51)34-6-8-38(42(23-34)61-35-22-31-11-15-47-43(31)49-26-35)44(54)50-62(57,58)37-7-9-40(41(24-37)53(55)56)48-27-36-29-59-20-21-60-36/h2-9,11,15,22-24,26,36,48H,1,10,12-14,16-21,25,27-29H2,(H,47,49)(H,50,54)/t36-/m0/s1
| Molecular Formula | C45H48ClN7O8S |
| Molecular Weight | 882.423 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Tue Apr 01 22:10:47 GMT 2025
by
admin
on
Tue Apr 01 22:10:47 GMT 2025
|
| Record UNII |
OSL3FEZ1IF
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
796420
Created by
admin on Tue Apr 01 22:10:47 GMT 2025 , Edited by admin on Tue Apr 01 22:10:47 GMT 2025
|
||
|
FDA ORPHAN DRUG |
757920
Created by
admin on Tue Apr 01 22:10:47 GMT 2025 , Edited by admin on Tue Apr 01 22:10:47 GMT 2025
|
||
|
FDA ORPHAN DRUG |
772320
Created by
admin on Tue Apr 01 22:10:47 GMT 2025 , Edited by admin on Tue Apr 01 22:10:47 GMT 2025
|
||
|
FDA ORPHAN DRUG |
787920
Created by
admin on Tue Apr 01 22:10:47 GMT 2025 , Edited by admin on Tue Apr 01 22:10:47 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2180923-05-9
Created by
admin on Tue Apr 01 22:10:47 GMT 2025 , Edited by admin on Tue Apr 01 22:10:47 GMT 2025
|
PRIMARY | |||
|
C156249
Created by
admin on Tue Apr 01 22:10:47 GMT 2025 , Edited by admin on Tue Apr 01 22:10:47 GMT 2025
|
PRIMARY | |||
|
137355972
Created by
admin on Tue Apr 01 22:10:47 GMT 2025 , Edited by admin on Tue Apr 01 22:10:47 GMT 2025
|
PRIMARY | |||
|
11787
Created by
admin on Tue Apr 01 22:10:47 GMT 2025 , Edited by admin on Tue Apr 01 22:10:47 GMT 2025
|
PRIMARY | |||
|
OSL3FEZ1IF
Created by
admin on Tue Apr 01 22:10:47 GMT 2025 , Edited by admin on Tue Apr 01 22:10:47 GMT 2025
|
PRIMARY | |||
|
300000031959
Created by
admin on Tue Apr 01 22:10:47 GMT 2025 , Edited by admin on Tue Apr 01 22:10:47 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET -> INHIBITOR |
IC50
|
||
|
|
TARGET -> INHIBITOR |
Disruption of Bcl-2-BIM complex and release of pro-apoptotic BIM
IC50
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |